Data were normalized for RNU6 expression by the comparative threshold cycle method. Triplicate Ct values were averaged, and the relative expression levels of the four ESCC cell lines were determined as 2Ct Statistical analysis Data were analyzed in GraphPad Prism 5. 0 and SPSS 13. 0. All P values were two sided, and the significance level was P 0. 05. A Mann Whitney U test was performed to compare the miR 34a methyla tion levels of every CpG site between the ESCC and control groups and between male and female subjects. The association between each CpG site methylation of miR 34a and the clinicopathologic parameters was evaluated by a nonparametric test. Spearman correlation was analyzed to evaluate the correlations between the CpG site methylation level of miR 34a and its expression levels.
Two sample t tests were conducted selleck chemical to compare the miR 34a expression between ESCC and normal tissues. Results Hypermethylation of miR 34a promoter in Kazakh patients with ESCC The MassARRAY system is a tool for the high throughput detection and quantitative analysis of methylation at a single CpG site at a target fragment that gen erates accurate data that represent the ratio or frequency of methylation events on a CpG site by MALDI TOF MS. This system was used to assess the methylation profile of miR 34a in all the samples collected from Kazakh patients with ESCC and from control subjects. The amplicon detected in the promoter regions of miR 34a was 318 base pairs in length and contained 23 CpG sites that can be divided into 15 CpG units. Among these CpG units, four CpG units yield unsuccessful measurements.
The final dataset con sisted of 11 CpG units, and the Etizolam clinical trial individual CpG unit methylation of miR 34a that distinguished ESCC from normal tissues is depicted in the cluster diagram. The patterns observed in the cluster analyses show that the methylation status of normal controls was notably different from that observed in tumor tissues. The overall methylation level of the tar get fragment of the miR 34a promoter was statistically higher in Kazakh esophageal cancer than in normal tissues. The methylation level of every CpG unit within the miR 34a promoter was also evaluated. Apart from that CpG 23, the mean methylation levels at were all significantly higher in patients with ESCC. Hypermethylated miR 34a in esophageal carcinoma is associated with metastasis development The association between the patterns of the quantitative methylation of every CpG unit within the miR 34a pro moter and the clinicopathologic features of the 59 Kazakh patients with ESCC was further evaluated. The CpG 5 and CpG 8. 9 methylation levels of miR 34a in lymph node metastasis tumor tissue were remarkably greater than those in tumor tissue without lymph node metastasis.
Related posts:
- Hence, these data imply that constitutive activation of PI K Akt
- The examination on the remaining descriptive data falls outside t
- The p21 mRNA while in the stroma was not diverse from that with
- Anti-MBP Antibody is thought to provide important biomarker data in addition to that obtained from blood
- C-Met Signaling Pathway receptor expression of transfected cDNA construct into pcDNA3